More about

Lymphoma

News
June 26, 2023
5 min read
Save

New Leukemia & Lymphoma Society president to focus on drug development, health disparities

New Leukemia & Lymphoma Society president to focus on drug development, health disparities

In his new role as president and CEO of The Leukemia & Lymphoma Society, pediatric hematologist oncologist E. Anders Kolb, MD, aims to expand his life’s work in advancing blood cancer research and therapies for patients of all ages.

News
June 23, 2023
1 min read
Save

Aldeyra Therapeutics advocates for expanded access for ADX-2191

Aldeyra Therapeutics advocates for expanded access for ADX-2191

Aldeyra Therapeutics will seek to make its investigational drug candidate ADX-2191 available to patients with primary vitreoretinal lymphoma under an FDA expanded access program, according to a press release.

News
June 22, 2023
7 min watch
Save

VIDEO: 'Potentially practice-changing' results from SWOG S1826 trial a highlight of ASCO

VIDEO: 'Potentially practice-changing' results from SWOG S1826 trial a highlight of ASCO

In this video, Joshua Brody, MD, discussed the results of the SWOG S1826 trial of nivolumab vs. brentuximab vedotin in advanced-stage classic Hodgkin lymphoma, which were presented at ASCO Annual Meeting.

News
June 20, 2023
1 min watch
Save

VIDEO: The future of lymphoma research

VIDEO: The future of lymphoma research

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses the future of DLBCL and non-Hodgkin lymphoma research.

News
June 20, 2023
1 min watch
Save

VIDEO: Health disparities in non-Hodgkin lymphoma care

VIDEO: Health disparities in non-Hodgkin lymphoma care

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses treatment disparities that exist for patients with DLBCL.

News
June 20, 2023
2 min watch
Save

VIDEO: The DLBCL treatment landscape

VIDEO: The DLBCL treatment landscape

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses the current treatment landscape for DLBCL.

News
June 20, 2023
1 min watch
Save

VIDEO: Highlights in non-Hodgkin lymphoma from ASCO 2023

VIDEO: Highlights in non-Hodgkin lymphoma from ASCO 2023

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses highlights in non-Hodgkin lymphoma from ASCO 2023.

News
June 20, 2023
1 min watch
Save

VIDEO: Take homes in DLBCL from ASCO 2023

VIDEO: Take homes in DLBCL from ASCO 2023

In this video, Matthew Matasar, MD, chief of the division of blood disorders at Rutgers Cancer Institute, discusses the latest research on DLBCL presented at ASCO 2023.

News
June 16, 2023
3 min watch
Save

VIDEO: Complimentary and alternative therapies for lymphoma

VIDEO: Complimentary and alternative therapies for lymphoma

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed alternative therapies for lymphoma.

News
June 16, 2023
2 min watch
Save

VIDEO: Using circulating tumor DNA to guide lymphoma therapy ‘a great area to explore’

VIDEO: Using circulating tumor DNA to guide lymphoma therapy ‘a great area to explore’

In this video, Jing-Zhou Hou, MD, PhD, medical oncologist and hematologist, clinical instructor and co-chair of the hematological malignancies program at UPMC Hillman Cancer Center, discussed using circulating tumor DNA to guide lymphoma therapy.

View more